Evidence map›Paper›PMID 42238283›Full record

ReviewSaudi medical journal2026

Management of Arrhythmias During Pregnancy in Africa.

Mervat Aboulmaaty, Kirellos Mikhail, Bola Sogade

Abstract readReview
In one paragraph

Review in Saudi medical journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Mervat AboulmaatyHeart Beat Center, Cairo, Egypt.ORCID 0000-0002-9032-4484
Kirellos MikhailAin Shams University, Department of Cardiology, Cairo, Egypt.
Bola SogadeObGyne Birth Center for Natural Deliveries (dba BirthEzy), Founder & Chief Medical Director, Forsyth, Georgia, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cardiac arrhythmias represent a significant clinical concern that have been always addressed. Moreover, Pregnancy introduces profound hormonal, autonomic, and hemodynamic changes that add more risk to cardiac patients and increase arrhythmia susceptibility. In our continent, Africa, there is an added risk because of the high prevalence of rheumatic heart disease, peripartum cardiomyopathy, and limited access to healthcare, contributing to adverse maternal and fetal outcomes. This article addresses the epidemics, mechanisms, and management of arrhythmias during pregnancy in African settings, highlighting high-yield real-life cases. We focus on guideline-based management strategies, emphasizing fetal safety, and discuss unique regional challenges, including limited access to drugs and restricted electrophysiology services. Data from a high-volume tertiary center in Egypt demonstrate that the key factors in such settings are multi-team cardio-obstetric care, timely intervention, and a balanced use of advanced electrophysiological techniques, which can achieve the best maternal and fetal outcomes despite constraints.

Indexed as

Arrhythmias, CardiacPregnancy Complications, CardiovascularAfricaAnti-Arrhythmia AgentsFemaleHumansPregnancyAnti-Arrhythmia AgentsAfricaAtrial fibrillationCardiac arrhythmiasCatheter ablationPregnancySupraventricular tachycardia

Identifiers

PMID42238283
PMCPMC13227441

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.